Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 86 | 61 | 75,651 | 49 | 44 |
| Gross Profit | 86 | 61 | 75,651 | 49 | 44 |
| Operating Expenses | 76,680 | 80,053 | 73,943 | 77,719 | 71,073 |
| Operating Income | -76,594 | -79,992 | 1,708 | -77,670 | -71,029 |
| Other Income | 1,807 | 142 | -1,622 | -516 | 93 |
| Pre-tax Income | -74,787 | -79,850 | 86 | -78,186 | -70,936 |
| Net Income Continuous | -74,787 | -79,850 | 86 | -78,186 | -70,936 |
| Net Income | $-74,787 | $-79,850 | $86 | $-78,186 | $-70,936 |
| EPS Basic Total Ops | -0.52 | -0.56 | 0.01 | -0.57 | -0.53 |
| EPS Basic Continuous Ops | -0.52 | -0.56 | 0.01 | -0.57 | -0.53 |
| EPS Diluted Total Ops | -0.52 | -0.56 | 0.01 | -0.57 | -0.53 |
| EPS Diluted Continuous Ops | -0.52 | -0.56 | 0.01 | -0.57 | -0.53 |
| EBITDA(a) | $-72,011 | $-74,968 | $7,544 | $-73,725 | $-67,230 |